Wanted: a cheap, multipotent treatment for viral infections. Must be able to handle new or unfamiliar strains, or (even ...

Opinions expressed by Digital Journal contributors are their own. Bringing a new biologic drug from concept to clinic is a complex journey fraught with technical and regulatory hurdles. For ...

WASHINGTON — Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to ...

Moving a potential therapy from the laboratory to the pharmacy has always been a slow, incremental journey. “Drug development is a multi-stage process,” says Nichola McCann, associate principal ...

Quick Read iShares Biotechnology ETF (IBB) returned 45% over the past year with $8.12B in assets and concentrates in large ...

This article summarizes a discussion at LSX Biopharm America on September 11. A panel of industry experts discussed approaches to overcoming the most urgent CMC challenges during the discussion. The ...

Malaria is a major global health problem. The therapeutic options are scarce and challenged by the emergence of resistant parasite strains, which causes a ...

By Sahil Pandey and Puyaan Singh April 14 (Reuters) - Amazon's cloud unit on Tuesday launched Amazon Bio Discovery, an ...

Dec 3 (Reuters) - Roivant (ROIV.O), opens new tab will discontinue the development of its drug for a rare lung disease after it failed to show treatment benefits in patients in a mid-stage trial.